Mechanisms underlying proglucagon gene expression

Journal of Endocrinology

Volumn 198, Issue 1, 2008, Pages 17-28

  Jin, Tianru ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HOMEODOMAIN PROTEIN; INSULIN; LIM PROTEIN; MESSENGER RNA; PROEIN ISL 1; PROGLUCAGON; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR BRN 4; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NKX6.2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PBX1; WNT PROTEIN;

CELL SPECIFICITY; CELL TYPE; DNA SEQUENCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; HORMONE SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; PAX2 TRANSCRIPTION FACTOR; POU DOMAIN FACTORS; PROGLUCAGON; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 47849093381     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0085     Document Type: Review

References (133)

1. Abraham EJ, Leech CA, Lin JC, Zulewski H & Habener JF 2002 Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 143 3152-3161.
2. Bell GI, Sanchez-Pescador R, Laybourn PJ & Najarian RC 1983a Exon duplication and divergence in the human preproglucagon gene. Nature 304 368-371.
3. \kern-2ptBell GI, Santerre RF & Mullenbach GT 1983b Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302 716-718.
4. Berthelsen J, Kilstrup-Nielsen C, Blasi F, Mavilio F & Zappavigna V 1999 The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. Genes and Development 13 946-953.
5. Bonner-Weir S & Weir GC 2005 New sources of pancreatic beta-cells. Nature Biotechnology 23 857-861.
6. Brubaker PL 1988 Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures. Endocrinology 123 220-226.
7. Brubaker PL & Drucker DJ 2004 Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145 2653-2659.
8. Brubaker PL, Schloos J & Drucker DJ 1998 Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139 4108-4114.
9. Burcelin R, Katz EB & Charron MJ 1996 Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes and Metabolism 22 373-396.
10. Cai J, Qi Y, Wu R, Modderman G, Fu H, Liu R & Qiu M 2001 Mice lacking the Nkx6.2 (Gtx) homeodomain transcription factor develop and reproduce normally. Molecular and Cellular Biology 21 4399-4403.
11. Campos RV, Lee YC & Drucker DJ 1994 Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134 2156-2164.
12. Chawengsaksophak K, James R, Hammond VE, Kontgen F & Beck F 1997 Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386 84-87.
13. Chen L, Wang P, Andrade CF, Zhao IY, Dube PE, Brubaker PL, Liu M & Jin T 2005 PKA independent and cell type specific activation of the expression of caudal homeobox gene Cdx-2 by cyclic AMP. FEBS Journal 272 2746-2759.
14. Christophe J 1996 Glucagon and its receptor in various tissues. Annals of the New York Academy of Sciences 805 31-42 discussion 42-33.
15. Diedrich T & Knepel W 1995 Interaction of the transcription factor CREB with pancreatic islet cell-specific enhancer elements. Biological Chemistry Hoppe-Seyler 376 39-44.
16. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z et al. 2005 Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Molecular Cell 19 159-170.
17. Doble BW & Woodgett JR 2003 GSK-3: tricks of the trade for a multi-tasking kinase. Journal of Cell Science 116 1175-1186.
18. Dong J, Asa SL & Drucker DJ 1991 Islet cell and extrapancreatic expression of the LIM domain homeobox gene isl-1. Molecular Endocrinology 5 1633-1641.
19. Doyle ME & Egan JM 2007 Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacology and Therapeutics 113 546-593.
20. Drucker DJ 2001 Minireview: the glucagon-like peptides. Endocrinology 142 521-527.
21. Drucker DJ 2002 Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 531-544.
22. Drucker DJ 2006 The biology of incretin hormones. Cell Metabolism 3 153-165.
23. Drucker DJ & Brubaker PL 1989 Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine. PNAS 86 3953-3957.
24. Drucker DJ, Campos R, Reynolds R, Stobie K & Brubaker PL 1991 The rat glucagon gene is regulated by a protein kinase A-dependent pathway in pancreatic islet cells. Endocrinology 128 394-400.
25. Drucker DJ, Jin T, Asa SL, Young TA & Brubaker PL 1994 Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Molecular Endocrinology 8 1646-1655.
26. Drucker DJ, Erlich P, Asa SL & Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. PNAS 93 7911-7916.
27. Efrat S, Teitelman G, Anwar M, Ruggiero D & Hanahan D 1988 Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron 1 605-613.
28. Elbein SC 2007 Evaluation of polymorphisms known to contribute to risk for diabetes in African and African-American populations. Current Opinion in Clinical Nutrition and Metabolic Care 10 415-419.
29. Ericson J, Thor S, Edlund T, Jessell TM & Yamada T 1992 Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1. Science 256 1555-1560.
30. Flock G & Drucker DJ 2002 Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine. Molecular Endocrinology 16 2349-2359.
31. Florez JC 2007 The new type 2 diabetes gene TCF7L2. Current Opinion in Clinical Nutrition and Metabolic Care 10 391-396.
32. Force T, Woulfe K, Koch WJ & Kerkela R 2007 Molecular scaffolds regulate bidirectional crosstalk between Wnt and classical seven-transmembrane-domain receptor signaling pathways. Science's STKE pe41.
33. Frayling TM 2007 A new era in finding type 2 diabetes genes-the unusual suspects. Diabetic Medicine 24 696-701.
34. Furstenau U, Schwaninger M, Blume R, Jendrusch EM & Knepel W 1999 Characterization of a novel calcium response element in the glucagon gene. Journal of Biological Chemistry 274 5851-5860.
35. Gajic D & Drucker DJ 1993 Multiple cis-acting domains mediate basal and adenosine 3′,5′-monophosphate-dependent glucagon gene transcription in a mouse neuroendocrine cell line. Endocrinology 132 1055-1062.
36. German MS, Wang J, Chadwick RB & Rutter WJ 1992 Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes and Development 6 2165-2176.
37. Gevrey JC, Malapel M, Philippe J, Mithieux G, Chayvialle JA, Abello J & Cordier-Bussat M 2004 Protein hydrolysates stimulate proglucagon gene transcription in intestinal endocrine cells via two elements related to cyclic AMP response element. Diabetologia 47 926-936.
38. Goncz E, Strowski MZ, Grotzinger C, Nowak KW, Kaczmarek P, Sassek M, Mergler S, El-Zayat BF, Theodoropoulou M, Stalla GK et al. 2008 Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway. Endocrinology 149 1618-1626.
39. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A et al. 2006 Variant of transcription factor 7-hke 2 (TCF7L2) gene confers risk oftype 2 diabetes. Nature Genetics 38 320-323.
40. Grarup N & Andersen G 2007 Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 10 420-426.
41. Habener JF, Kemp DM & Thomas MK 2005 Minireview: transcriptional regulation in pancreatic development. Endocrinology 146 1025-1034.
42. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B & Kinzler KW 1998 Identification of c-MYC as a target of the APC pathway. Science 281 1509-1512.
43. Heinrich G, Gros P, Lund PK, Bentley RC & Habener JF 1984 Pre-proglucagon messenger ribonucleic acid: nucleotide and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid. Endocrinology 115 2176-2181.
44. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD & Serup P 2003 Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expression 11 141-147.
45. Heller RS, Stoffers DA, Liu A, Schedl A, Crenshaw EB, III, Madsen OD & Serup P 2004 The role of Brn4/Pou3f4 and Pax6 in forming the pancreatic glucagon cell identity. Developmental Biology 268 123-134.
46. Henseleit KD, Nelson SB, Kuhlbrodt K, Hennings JC, Ericson J & Sander M 2005 NKX6 transcription factor activity is required for α- and β-cell development in the pancreas. Development 132 3139-3149.
47. Herzig S, Fuzesi L & Knepel W 2000 Heterodimeric Pbx-Prep1 homeodomain protein binding to the glucagon gene restricting transcription in a cell type-dependent manner. Journal of Biological Chemistry 275 27989-27999.
48. Holst JJ 2006 Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 49 253-260.
49. Holz GG 2004 New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic β-cells. Hormone and Metabolic Research 36 787-794.
50. Hussain MA & Habener JF 1999 Glucagon gene transcription activation mediated by synergistic interactions of pax-6 and cdx-2 with the p300 co-activator. Journal of Biological Chemistry 274 28950-28957.
51. Hussain MA, Lee J, Miller CP & Habener JF 1997 POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Molecular and Cellular Biology 17 7186-7194.
52. Hussain MA, Miller CP & Habener JF 2002 Brn-4 transcription factor expression targeted to the early developing mouse pancreas induces ectopic glucagon gene expression in insulin-producing beta cells. Journal of Biological Chemistry 277 16028-16032.
53. Irwin DM 2001 Molecular evolution of proglucagon. Regulatory Peptides 98 1-12.
54. Jelinek LJ, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA et al. 1993 Expression cloning and signaling properties of the rat glucagon receptor. Science 259 1614-1616.
55. Jeppesen PB 2003 Clinical significance of GLP-2 in short-bowel syndrome. Journal of Nutrition 133 3721-3724.
56. Jin T & Drucker DJ 1995 The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcription. Molecular Endocrinology 9 1306-1320.
57. Jin T & Drucker DJ 1996 Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3. Molecular and Cellular Biology 16 19-28.
58. Jin T, Trinh DK, Wang F & Drucker DJ 1997 The caudal homeobox protein cdx-2/3 activates endogenous proglucagon gene expression in InR1-G9 islet cells. Molecular Endocrinology 11 203-209.
59. Karlsson O, Thor S, Norberg T, Ohlsson H & Edlund T 1990 Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain. Nature 344 879-882.
60. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE & Graybiel AM 1998 A family of cAMP-binding proteins that directly activate Rapl. Science 282 2275-2279.
61. Kieffer TJ 2004 Gastro-intestinal hormones GIP and GLP-1. Annales d'Endocrinologie 65 13-21.
62. Kim SK, Selleri L, Lee JS, Zhang AY, Gu X, Jacobs Y & Cleary ML 2002 Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nature Genetics 30 430-435.
63. Knepel W, Chafitz J & Habener JF 1990 Transcriptional activation of the rat glucagon gene by the cyclic AMP-responsive element in pancreatic islet cells. Molecular and Cellular Biology 10 6799-6804.
64. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ & Clevers H 1998 Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 19 379-383.
65. Laser B, Meda P, Constant I & Philippe J 1996 The caudal-related homeodomain protein Cdx-2/3 regulates glucagon gene expression in islet cells. Journal of Biological Chemistry 271 28984-28994.
66. Lee YC, Asa SL & Drucker DJ 1992 Glucagon gene 5′-flanking sequences direct expression of sumian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. Journal of Biological Chemistry 267 10705-10708.
67. List JF & Habener JF 2004 Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells. American Journal of Physiology. Endocrinology and Metabolism 286 E875-E881.
68. Liu Z & Habener JF 2008. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic β-cell proliferation. Journal of Biological Chemistry 283 8723-8735.
69. Liu T, Branch DR & Jin T 2006 Pbx1 is a co-factor for Cdx-2 in regulating proglucagon gene expression in pancreatic A cells. Molecular and Cellular Endocrinology 249 140-149.
70. Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S & Wareham NJ 2007 TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56 1943-1947.
71. Lopez LC, Frazier ML, Su CJ, Kumar A & Saunders GF 1983 Mammalian pancreatic preproglucagon contains three glucagon-related peptides. PNAS 80 5485-5489.
72. Lotfi S, Li Z, Sun J, Zuo Y, Lain PP, Kang Y, Rahimi M, Islam D, Wang P, Gaisano HY & Jin T 2006 Role of the exchange protein directly activated by cyclic adenosine 5′-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. Endocrinology 147 3727-3736.
73. Lu F, Jin T & Drucker DJ 1996 Proglucagon gene expression is induced by gastrin-releasing peptide in a mouse enteroendocrine cell line. Endocrinology 137 3710-3716.
74. Lund PK, Goodman RH, Dee PC & Habener JF 1982 Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. PNAS 79 345-349.
75. Lyssenko, V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL et al. 2007 Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 117 2155-2163.
76. Ma X, Zhang Y, Gromada J, Sewing S, Berggren PO, Buschard K, Salehi A, Vikman J, Rorsman P & Eliasson L 2005 Glucagon stimulates exocytosis in mouse and rat pancreatic α-cells by binding to glucagon receptors. Molecular Endocrinology 19 198-212.
77. Malbon CC 2004 Frizzleds: new members of the superfamily of G-protein-coupled receptors. Frontiers in Bioscience 9 1048-1058.
78. McKinnon CM, Ravier MA & Rutter GA 2006 FoxO1 is required for the regulation of preproglucagon gene expression by insulin in pancreatic alphaTC1-9 cells. Journal of Biological Chemistry 281 39358-39369.
79. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP et al. 1999 Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140 244-250.
80. Moon RT, Brown JD & Torres M 1997 WNTs modulate cell fate and behavior during vertebrate development. Trends in Genetics 13 157-162.
81. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B & Kinzler KW 1997 Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 1787-1790.
82. Murphy KG, Dhillo WS & Bloom SR 2006 Gut peptides in the regulation of food intake and energy homeostasis. Endocrine Reviews 27 719-727.
83. Nelson SB, Schaffer AE & Sander M 2007 The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1 + pancreatic progenitor cells. Development 134 2491-2500.
84. Ni Z, Anini Y, Fang X, Mills G, Brubaker PL & Jin T 2003 Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells. Journal of Biological Chemistry 278 1380-1387.
85. Nian M, Drucker DJ & Irwin D 1999 Divergent regulation of human and rat proglucagon gene promoters in vivo. American Journal of Physiology 277 G829-G837.
86. Nian M, Gu J, Irwin DM & Drucker DJ 2002 Human glucagon gene promoter sequences regulating tissue-specific versus nutrient-regulated gene expression. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 282 R173-R183.
87. Owen KR & McCarthy MI 2007 Genetics of type 2 diabetes. Current Opinion in Genetics and Development 17 239-244.
88. Pedersen JK, Nelson SB, Jorgensen MC, Henseleit KD, Fujitani Y, Wright CV, Sander M & Serup P 2005 Endodermal expression of Nkx6 genes depends differentiafly on Pdx1. Developmental Biology 288 487-501.
89. Peifer M & Polakis P 2000 Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287 1606-1609.
90. Peng SY, Wang WP, Meng J, Li T, Zhang H, Li YM, Chen P, Ma KT & Zhou CY 2005 ISL1 physically interacts with BETA2 to promote insulin gene transcriptional synergy in non-beta cells. Biochimica et Biophysica Acta 1731 154-159.
91. Pfaff SL, Mendelsohn M, Stewart CL, Edlund T & Jessell TM 1996 Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 84 309-320.
92. Philippe J 1989 Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. Journal of Clinical Investigation 84 672-677.
93. Philippe J 1991 Insulin regulation of the glucagon gene is mediated by an insulin-responsive DNA element. PNAS 88 7224-7227.
94. Philippe J, Drucker DJ, Chick WL & Habener JF 1987a Transcriptional regulation of genes encoding insulin, glucagon, and angiotensinogen by sodium butyrate in a rat islet cell line. Molecular and Cellular Biology 7 560-563.
95. Philippe J, Drucker DJ & Habener JF 1987b Glucagon gene transcription in an islet cell line is regulated via a protein kinase C-activated pathway. Journal of Biological Chemistry 262 1823-1828.
96. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Molecular Endocrinology 15 209-218.
97. Ritz-Laser B, Estreicher A, Klages N, Saule S & Philippe J 1999 Pax-6 and Cdx-2/3 interact to activate glucagon gene expression on the G1 control element. Journal of Biological Chemistry 274 4124-4132.
98. Ritz-Laser B, Estreicher A, Gauthier B & Philippe J 2000 The paired homeodomain transcription factor Pax-2 is expressed in the endocrine pancreas and transactivates the glucagon gene promoter. Journal of Biological Chemistry 275 32708-32715.
99. Ritz-Laser B, Estreicher A, Gauthier BR, Mamin A, Edlund H & Philippe J 2002 The pancreatic β-cell-specific transcription factor Pax-4 inhibits glucagon gene expression through Pax-6. Diabetologia 45 97-107.
100. Ritz-Laser B, Mamin A, Brun T, Avril I, Schwitzgebel VM & Philippe J 2005 The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expression. Molecular Endocrinology 19 759-770.
101. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A & Bos JL 1998 Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 474-477.
102. Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR & German MS 1997 Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes and Development 11 1662-1673.
103. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F, Schwitzgebel V, Hayes-Jordan A & German M 2000 Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127 5533-5540.
104. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, T'Hart LM, Nijpels G et al. 2007 Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50 2443-2450.
105. Schinner S, Barthel A, Dellas C, Grzeskowiak R, Sharma SK, Oetjen E, Blume R & Knepel W 2005 Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. Journal of Biological Chemistry 280 7369-7376.
106. Schisler JC, Jensen PB, Taylor DG, Becker TC, Knop FK, Takekawa S, German M, Weir GC, Lu D, Mirmira RG & Newgard CB 2005 The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. PNAS 102 7297-7302.
107. Schwaninger M, Lux G, Blume R, Oetjen E, Hidaka H & Knepel W 1993 Membrane depolarization and calcium influx induce glucagon gene transcription in pancreatic islet cells through the cyclic AMP-responsive element. Journal of Biological Chemistry 268 5168-5177.
108. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL & Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nature Medicine 2 1254-1258.
109. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J & Maedler K 2008 TCF7L2 regulates -cell survival and function in human pancreatic islets. Diabetes 57 645-653.
110. Sinclair EM & Drucker DJ 2005 Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology 20 357-365.
111. Stambolic V, Ruel L & Woodgett JR 1996 Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology 6 1664-1668.
112. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A & Gruss P 1997 Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 387 406-409.
113. Stoykova A, Fritsch R, Walther C & Gruss P 1996 Forebrain patterning defects in small eye mutant mice. Development 122 3453-3465.
114. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, Meneses JJ, Pedersen RA, Rubenstein JL & German MS 1998 Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic β-cells. Development 125 2213-2221.
115. Thor S, Ericson J, Brannstrom T & Edlund T 1991 The homeodomain LIM protein Isl-1 is expressed in subsets of neurons and endocrine cells in the adult rat. Neuron 7 881-889.
116. Thyssen S, Arany E & Hill DJ 2006 Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 147 2346-2356.
117. Trinh DK, Zhang K, Hossain M, Brubaker PL & Drucker DJ 2003 Pax-6 activates endogenous proglucagon gene expression in the rodent gastrointestinal epithelium. Diabetes 52 425-433.
118. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD et al. 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 69-72.
119. Vallejo M, Penchuk L & Habener JF 1992 Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors. Journal of Biological Chemistry 267 12876-12884.
120. Vilsboll T, Krarup T, Deacon CF, Madsbad S & Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50 609-613.
121. Wang M & Drucker DJ 1995 The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. Journal of Biological Chemistry 270 12646-12652.
122. Wang H, Maechler P, Ritz-Laser B, Hagenfeldt KA, Ishihara H, Philippe J & Wollheim CB 2001 Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. Journal of Biological Chemistry 276 25279-25286.
123. Wang J, Cao Y & Steiner DF 2003 Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter. Journal of Biological Chemistry 278 32899-32904.
124. Wang P, Liu T, Li Z, Ma X &Jin T 2006 Redundant and synergistic effect of Cdx-2 and Brn-4 on regulating proglucagon gene expression. Endocrinology 147 1950-1958.
125. Wideman RD, Yu IL, Webber TD, Verchere CB, Johnson JD, Cheung AT & Kieffer TJ 2006 Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). PNAS 103 13468-13473.
126. Wideman RD, Covey SD, Webb GC, Drucker DJ & Kieffer TJ 2007 A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice. Diabetes 56 2744-2752.
127. Wilson ME, Kalamaras JA & German MS 2002 Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mechanism of Development 115 171-176.
128. Xu F, Li H & Jin T 1999 Cell type-specific autoregulation of the Caudal-related homeobox gene Cdx-2/3. Journal of Biological Chemistry 274 34310-34316.
129. Yi F, Brubaker PL &Jin T 2005 TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3beta. Journal of Biological Chemistry 280 1457-1464.
130. Yi F, Sun J, Lim GE, Famus IG, Brubaker PL &Jin T 2008. Crosstalk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology (In Press).
131. Zaiko M, Estreicher A, Ritz-Laser B, Herrera P, Favor J, Meda P & Philippe J 2004 Pax2 mutant mice display increased number and size of islets of Langerhans but no change in insulin and glucagon content. European Journal of Endocrinology 150 389-395.
132. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J & He X 2005 A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438 873-877.
133. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ & Steiner DF 2002 Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. PNAS 99 10293-10298.